This truly remarkable time in the biological sciences has the opportunity to effectively attack some of the most fundamental problems of society.
The clinical trial at the Oregan Health & Science University was performed to treat a blindness-causing gene mutation.
Though scientists are optimistic that CRISPR could help, they also emphasize caution and community engagement in order to get it right.
From zinc fingers to TALE, to CRISPR/Cas9 to base editing and now to prime editing, progress in gene editing has been accelerating.
On the horizon is the applicability of the technology to Duchenne muscular dystrophy and myotonic dystrophy type 1.
Scientists have cloned a genetically engineered bull which they hope will help heart valve transplant patients lead better quality lives.
It is difficult to examine society’s acceptance or rejection of key biotech developments without considering the role played by major religions.
The Human Genome Project launched in 1990 with the goal to read genomes. Now scientists are working to write them.
At MIT’s Center for Neural Circuit Genetics, for example, scientists have modified memories in mice using an optogenetic interface.
People expect health care products that are medically beneficial to be available to more than just those people who can pay for them.